Hikma Pharmaceuticals PLC (LON:HIK)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1,636.00
+12.00 (0.74%)
Aug 21, 2026, 4:35 PM GMT

Hikma Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
387402359190188421
Depreciation & Amortization
210204189190185169
Other Amortization
7888811
Loss (Gain) From Sale of Assets
111--61
Asset Writedown & Restructuring Costs
3626-2961179-35
Loss (Gain) From Sale of Investments
--1-1-22-
Loss (Gain) on Equity Investments
---1--1
Stock-Based Compensation
232327252229
Other Operating Activities
10624146568369
Change in Accounts Receivable
-35-97-144-244-166
Change in Inventory
-106-86-112-115-10238
Change in Accounts Payable
73878881614
Change in Other Net Operating Assets
-147-10643131-4986
Operating Cash Flow
489436564608530638
Operating Cash Flow Growth
-7.21%-22.70%-7.24%14.72%-16.93%37.50%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-251-197-165-169-138-145
Sale of Property, Plant & Equipment
-1-10181-
Cash Acquisitions
---150-98-373-
Divestitures
-----1-
Sale (Purchase) of Intangibles
-47-120-70-35-78-84
Investment in Securities
--2-2-26-153
Other Investing Activities
-24-69-4-23-3-12
Investing Cash Flow
-323-388-381-333-607-238

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-349387437380383
Long-Term Debt Issued
-2,4026847781,40110
Total Debt Issued
2,9032,7511,0711,2151,781393
Short-Term Debt Repaid
--357-411-467-363-431
Long-Term Debt Repaid
--2,104-557-851-971-76
Total Debt Repaid
-2,542-2,461-968-1,318-1,334-507
Net Debt Issued (Repaid)
361290103-103447-114
Repurchase of Common Stock
-209-36-38--300-
Common Dividends Paid
-184-185-175-137-125-120
Other Financing Activities
-106-94-78-97-80-53
Financing Cash Flow
-138-25-188-337-58-287

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-16-12-3-21-10
Net Cash Flow
2729-17-65-156103

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
238239399439392493
Free Cash Flow Growth
-34.44%-40.10%-9.11%11.99%-20.49%68.84%
Free Cash Flow Margin
6.96%7.14%12.76%15.27%15.57%19.31%
Free Cash Flow Per Share
1.081.071.781.971.742.12
Levered Free Cash Flow
14.38-66.13293.88449244.38269.75
Unlevered Free Cash Flow
75-13340.75494.63281.25296.63

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
948384826850
Cash Income Tax Paid
12712412512955129
Change in Working Capital
-281-251-13580-131-28